Thoracic Paravertebral Block with Liposomal Bupivacaine Versus Plain Bupivacaine in Patients Undergoing Thoracoscopic Lung Resection: A Randomized Controlled Study
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s532122 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Zhen Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Xiamen Zhongshan Hospital, Fudan University, Xiamen, Fujian, People's Republic of China. Hauptthemen laut MEDLINE: Anesthetics, Local, Bupivacaine, Nerve Block, Postoperative Pain. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
The effectiveness of a thoracic paravertebral blockade with liposomal bupivacaine for thoracic surgery pain management is not well examined. This study compared the effects of liposomal bupivacaine and plain bupivacaine on a thoracic paravertebral blockade in adult patients undergoing video-assisted thoracoscopic surgery (VATS).
Methods
Consenting participants (114) scheduled for VATS were randomly assigned to thoracic paravertebral blockade at T4-5 and T7-8 levels with 20 mL (266 mg) liposomal bupivacaine (LB) or 20 mL (37.5 mg) plain bupivacaine (PB) groups. The primary endpoint was opioid consumption at 48 hours postoperatively. Additional main outcomes included the opioid consumption 24 and 72 hours postoperatively; the pain score at rest and coughing 24, 48, and 72 hours postoperatively; Quality of Recovery-15 (QoR-15) scores 24 hours postoperatively, the time to the first analgesia request.
Results
Opioid consumption did not differ between the groups at 48 hours postoperatively. The QoR-15 scores 24 hours after surgery were higher in the LB group than in the PB group (mean [SD], 120.2 [7.1] vs 116.5 [7.8]; P = 0.009). The time to the first analgesia request was longer in the LB group than in the PB group (mean [SD], 585.8min [211.7] vs 315.3min [101.7]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Xiamen Zhongshan Hospital, Fudan University, Xiamen, Fujian, People's Republic of China.
- Department of Anesthesiology, Shanghai Geriatric Medical Center, Fudan University, Shanghai, People's Republic of China.
- Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
ORCID-Profile: Zhen Yang
Zitieren
APA
Yang, Z., Liu, M., Wang, C., Song, Y., Wu, J., Wu, D., Yao, M., Yang, Y., Miao, C., & Liang, C. (2025). Thoracic Paravertebral Block with Liposomal Bupivacaine Versus Plain Bupivacaine in Patients Undergoing Thoracoscopic Lung Resection: A Randomized Controlled Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s532122
Vancouver
Yang Z, Liu M, Wang C, Song Y, Wu J, Wu D, et al. Thoracic Paravertebral Block with Liposomal Bupivacaine Versus Plain Bupivacaine in Patients Undergoing Thoracoscopic Lung Resection: A Randomized Controlled Study. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s532122
BibTeX
@article{Yang2025,
author = {Yang, Zhen and Liu, Manman and Wang, Chengyu and Song, Yuejiao and Wu, Junmei and Wu, Dan and Yao, Minmin and Yang, Yan and Miao, Changhong and Liang, Chao},
title = {Thoracic Paravertebral Block with Liposomal Bupivacaine Versus Plain Bupivacaine in Patients Undergoing Thoracoscopic Lung Resection: A Randomized Controlled Study},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s532122}
}
EUVIMED